Clinical Trial Update: Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial update announcing a study to evaluate zinc supplementation for improving prognosis in patients with compensated advanced chronic liver disease, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease
• Portal Hypertension

Drugs mentioned

• Zinc supplementation (zinc)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Advanced Chronic Liver Disease, Portal Hypertension | Phase 3 | Status: RECRUITING